Skip to content

Pilot Study of Time Restricted Feeding as a Weight Loss Intervention

Pilot Study of Time Restricted Feeding as a Weight Loss Intervention in Overweight and Obese Adults

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03571048
Enrollment
95
Registered
2018-06-27
Start date
2018-06-01
Completion date
2020-11-12
Last updated
2022-10-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Obesity

Brief summary

The circadian timing of Energy Intake (EI) has emerged as a key factor in the regulation of body weight. Studies have suggested that eating later in the evening or at night when the circadian system is promoting sleep adversely influences weight loss. In contrast, restricting EI to a short window during waking hours and extending the length of the overnight fast (i.e., time restricted feeding, TRF) may be a practical and useful weight loss strategy. The overall objective of this proposal is to provide a foundation to inform the design of a future large-scale trial to evaluate the efficacy of TRF in generating weight loss. The investigators aims are to: 1) Assess processes critical for the success of a large-scale trial comparing the efficacy of a reduced calorie diet with time restricted feeding (RCD+TRF) versus standard RCD on weight loss; 2) Develop methodology to assess compliance to the RCD+TRF versus standard RCD program and collect preliminary data on whether the programs have differential effects on free-living behaviors (EI, appetite, physical activity, and sedentary behavior); and 3) Measure metabolic responses to RCD+TRF versus standard RCD to determine candidate mechanisms related to weight loss at 12wks and weight maintenance at 6mo post-intervention. The investigators primary hypothesis is that weight loss will be greater in the TRF group compared to the RCD group.

Detailed description

The circadian timing of energy intake (EI) has emerged as a key factor in the regulation of body weight. Studies have suggested that eating meals later in the evening or during the biological night when the circadian system is promoting sleep adversely influences the success of weight loss therapy. In contrast, restricting EI to a short window during waking hours and extending the length of the overnight fast (i.e., time restricted feeding, TRF) may be a practical and useful strategy for promoting weight loss and weight maintenance. However, potential benefits of adding TRF to a weight loss program have yet to be evaluated in a well-controlled clinical study. The overall objective of this proposal is to provide a foundation to inform the design of a future large-scale trial to evaluate the efficacy of TRF in generating weight loss. The investigators overall hypothesis is that feasibility, adherence, and acceptability of a weight loss intervention using TRF in the setting of a reduced calorie diet (RCD) - RCD+TRF - will be similar to compliance with an intervention using a reduced calorie diet alone (RCD), suggesting acceptability for a future large-scale trial. In this 12-week pilot and feasibility study, 30 overweight and obese individuals will be randomized 1:1 to RCD+TRF (EI restricted to a 10-hour window starting 1 hour from habitual waking time) or standard RCD (no restriction on feeding duration). Additional follow-up will occur at 6 months to collect pilot data on weight maintenance. Measures include feasibility, acceptability and adherence to the interventions, body weight, body composition (Dual-energy X-ray absorptiometry (DXA)), EI (smart phone application), physical activity (PA, accelerometery), glucose variability (continuous glucose monitoring, CGM), sleep (questionnaires and polysomnography), and nocturnal substrate metabolism (room calorimetry). The specific aims (SA) are as follows: Specific Aim 1a. To evaluate the feasibility and acceptability of a 12-week TRF intervention compared to a standard dietary weight loss intervention (i.e. RCD). Feasibility of enrollment and retention, and acceptability of the intervention will be assessed in adults with obesity meeting inclusion/exclusion criteria proposed for the future large-scale trial. The investigators will assess adherence to the weight loss programs, as measured objectively with a novel smartphone application and verified with CGM data, and subjectively with the use of questionnaires. Specific Aim 1b. To assess the efficacy of RCD+TRF compared to RCD alone in producing weight loss at 12 weeks and reducing the risk of weight regain after 6 months of follow-up.

Interventions

Participants will be given an individualized calorie goal. Participants in this group will also receive a 12 week comprehensive group-based behavioral weight loss program and will be instructed in specific strategies to support RCD.

Participants will be given an individualized calorie goal. Participants in this group will also receive a 12 week comprehensive group-based behavioral weight loss program and will be instructed in specific strategies to support RCD. Participants in this group will also instructed to eat only during a window of 10 hours, starting within 3 hours of waking. They will also be instructed in specific strategies to support TRF including: strategies to deal with hunger outside eating windows, distraction techniques, and choosing a balanced diet/appropriate portions during feeding windows.

Sponsors

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
CollaboratorNIH
University of Colorado, Denver
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 50 Years
Healthy volunteers
Yes

Inclusion criteria

* Adult males and females with a BMI of 27-45 kg/m2 and weight stable over the previous 6 months; * Age, 18-50 years old; * Passing medical and physical screening, and analysis of blood and urine screening samples; * Typical eating duration \>12 hours per day (assessed by questionnaires); * Own a smartphone

Exclusion criteria

* Pregnancy or lactation for women (women who are \>6 months postpartum with no plans of becoming pregnant in the next year and who are not currently lactating can be included; oral contraceptives will be allowed if medication has been consistent for the prior 6 months) * Postmenopausal women (menopausal status will be assessed during the history and physical, with requirement of self-reported regular menstrual cycles for the last year; women who have undergone hysterectomy but with ovaries in place who continue to have regular menstrual symptoms can be included) * Being considered unsafe to participate as determined by the study physician; * History of cardiovascular disease, diabetes, uncontrolled hypertension, untreated thyroid, renal, hepatic diseases, dyslipidemia or any other medical condition affecting weight or lipid metabolism; * History of human immunodeficiency virus or hepatitis B or C (self-report); * Taking medications affecting weight or energy intake/energy expenditure in the last 6 months, including weight loss medications, antipsychotic drugs or other medications as determined by the study physician; * Having abnormal blood chemistry (eGFR\<45mL/min, AST or ALT \>3 times the upper limit of normal) or as deemed significant by the study physician; * Being a smoker or having been a smoker in the 3 months prior to their screening visit; * Working night shifts; * Extreme early or extreme late chronotype as determined by the Munich Chronotype questionnaire37; * Night eating syndrome (at least 25% of food intake is consumed after the evening meal and/or at least two episodes of nocturnal eating per week) as assessed with meal pattern assessment questionnaire; * For participants completing the PSG studies, greater than moderate sleep apnea (score high risk ≥ 2 or more categories on the Berlin Questionnaire). Participants completing the primary weight loss intervention will not be excluded based on Berlin OSA risk scores. * For participants completing the PSG studies, use of medications affecting sleep (benzodiazepines and other sleep aids, as determined by study physician). Participants completing the primary weight loss intervention will not be excluded based on use of medications affecting sleep.

Design outcomes

Primary

MeasureTime frameDescription
Changes in Body WeightBaseline, 12 weeksBody weight will be measured via clinic scale.

Secondary

MeasureTime frameDescription
Changes in Objectively Measured Energy Intake (Camera)Baseline, 12 weeksAll energy intake events will be recorded using the camera function on a cell phone application
Changes in Physical ActivityBaseline, 12 weeksStep count will be measured with activity monitors.
Changes in Fat MassBaseline, 12 weeksBody composition will be assessed with dual-energy x-ray absorptiometry (DXA).
Changes in Sedentary BehaviorBaseline, 12 weeksSitting time will be measured with activity monitors.

Other

MeasureTime frameDescription
6 Month Post-Intervention Follow-Up Body Weight24 weeks after completion of the 12-week intervention (i.e. at week 36)Body weight will be measured via clinic scale at 6 months post-intervention
6 Month Post-Intervention Follow-Up Fat Mass24 weeks after completion of the 12-week intervention (i.e. at week 36)Body composition will be assessed with dual-energy x-ray absorptiometry (DXA).

Countries

United States

Participant flow

Participants by arm

ArmCount
Reduced Calorie Diet (RCD)
Participants in this group will focus on daily calorie restriction as their dietary weight loss strategy. Reduced Calorie Diet (RCD): Participants will be given an individualized calorie goal. Participants in this group will also receive a 12 week comprehensive group-based behavioral weight loss program and will be instructed in specific strategies to support RCD.
40
Time Restricted Feeding (TRF)
Participants in this group will focus on time restricted feeding in addition to daily calorie restriction as their dietary weight loss strategy. Reduced Calorie Diet (RCD): Participants will be given an individualized calorie goal. Participants in this group will also receive a 12 week comprehensive group-based behavioral weight loss program and will be instructed in specific strategies to support RCD. Time Restricted Feeding (TRF): Participants will be given an individualized calorie goal. Participants in this group will also receive a 12 week comprehensive group-based behavioral weight loss program and will be instructed in specific strategies to support RCD. Participants in this group will also instructed to eat only during a window of 10 hours, starting within 3 hours of waking. They will also be instructed in specific strategies to support TRF including: strategies to deal with hunger outside eating windows, distraction techniques, and choosing a balanced diet/appropriate portions during feeding windows.
41
Total81

Baseline characteristics

CharacteristicReduced Calorie Diet (RCD)Time Restricted Feeding (TRF)Total
Age, Categorical
<=18 years
0 Participants0 Participants0 Participants
Age, Categorical
>=65 years
0 Participants0 Participants0 Participants
Age, Categorical
Between 18 and 65 years
40 Participants41 Participants81 Participants
Age, Continuous37.8 years
STANDARD_DEVIATION 7.8
38.3 years
STANDARD_DEVIATION 7.9
38 years
STANDARD_DEVIATION 7.8
Ethnicity (NIH/OMB)
Hispanic or Latino
7 Participants6 Participants13 Participants
Ethnicity (NIH/OMB)
Not Hispanic or Latino
32 Participants35 Participants67 Participants
Ethnicity (NIH/OMB)
Unknown or Not Reported
1 Participants0 Participants1 Participants
Race (NIH/OMB)
American Indian or Alaska Native
0 Participants0 Participants0 Participants
Race (NIH/OMB)
Asian
5 Participants0 Participants5 Participants
Race (NIH/OMB)
Black or African American
5 Participants4 Participants9 Participants
Race (NIH/OMB)
More than one race
0 Participants0 Participants0 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants0 Participants0 Participants
Race (NIH/OMB)
Unknown or Not Reported
0 Participants1 Participants1 Participants
Race (NIH/OMB)
White
30 Participants36 Participants66 Participants
Region of Enrollment
United States
40 participants41 participants81 participants
Sex: Female, Male
Female
35 Participants34 Participants69 Participants
Sex: Female, Male
Male
5 Participants7 Participants12 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
0 / 400 / 41
other
Total, other adverse events
0 / 400 / 41
serious
Total, serious adverse events
0 / 400 / 41

Outcome results

Primary

Changes in Body Weight

Body weight will be measured via clinic scale.

Time frame: Baseline, 12 weeks

ArmMeasureValue (MEAN)Dispersion
Reduced Calorie Diet (RCD)Changes in Body Weight-5.1 kgStandard Deviation 3.2
Time Restricted Feeding (TRF)Changes in Body Weight-6.2 kgStandard Deviation 4.1
Secondary

Changes in Fat Mass

Body composition will be assessed with dual-energy x-ray absorptiometry (DXA).

Time frame: Baseline, 12 weeks

ArmMeasureValue (MEAN)Dispersion
Reduced Calorie Diet (RCD)Changes in Fat Mass-2.1 kgStandard Deviation 2.6
Time Restricted Feeding (TRF)Changes in Fat Mass-2.8 kgStandard Deviation 1.8
Secondary

Changes in Objectively Measured Energy Intake (Camera)

All energy intake events will be recorded using the camera function on a cell phone application

Time frame: Baseline, 12 weeks

ArmMeasureValue (MEAN)Dispersion
Reduced Calorie Diet (RCD)Changes in Objectively Measured Energy Intake (Camera)-612.2 kcalStandard Deviation 476
Time Restricted Feeding (TRF)Changes in Objectively Measured Energy Intake (Camera)-647.3 kcalStandard Deviation 773
Secondary

Changes in Physical Activity

Step count will be measured with activity monitors.

Time frame: Baseline, 12 weeks

ArmMeasureValue (MEAN)Dispersion
Reduced Calorie Diet (RCD)Changes in Physical Activity576 steps/dayStandard Deviation 3172
Time Restricted Feeding (TRF)Changes in Physical Activity596 steps/dayStandard Deviation 2731
Secondary

Changes in Sedentary Behavior

Sitting time will be measured with activity monitors.

Time frame: Baseline, 12 weeks

ArmMeasureValue (MEAN)Dispersion
Reduced Calorie Diet (RCD)Changes in Sedentary Behavior-19.8 minutes/dayStandard Deviation 88
Time Restricted Feeding (TRF)Changes in Sedentary Behavior-0.77 minutes/dayStandard Deviation 82
Other Pre-specified

6 Month Post-Intervention Follow-Up Body Weight

Body weight will be measured via clinic scale at 6 months post-intervention

Time frame: 24 weeks after completion of the 12-week intervention (i.e. at week 36)

ArmMeasureValue (MEAN)Dispersion
Reduced Calorie Diet (RCD)6 Month Post-Intervention Follow-Up Body Weight-4.3 kgStandard Deviation 5.3
Time Restricted Feeding (TRF)6 Month Post-Intervention Follow-Up Body Weight-4.9 kgStandard Deviation 5.3
Other Pre-specified

6 Month Post-Intervention Follow-Up Fat Mass

Body composition will be assessed with dual-energy x-ray absorptiometry (DXA).

Time frame: 24 weeks after completion of the 12-week intervention (i.e. at week 36)

ArmMeasureValue (MEAN)Dispersion
Reduced Calorie Diet (RCD)6 Month Post-Intervention Follow-Up Fat Mass-2.6 kgStandard Deviation 4.4
Time Restricted Feeding (TRF)6 Month Post-Intervention Follow-Up Fat Mass-3.5 kgStandard Deviation 4

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026